Cross-sectional Association Between Plasma Aldosterone Concentration and Cognitive Performance by Mini-mental State Examination in Community Dwellers

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2025 Feb 21

PMID 39980672

Authors

Aketilieke Nusufujiang

Mulalibieke Heizhati

Nanfang Li

Ling Yao

Wenbo Yang

Hui Wang

Mei Li

Lin Gan

Adalaiti Maitituersun

Miaomiao Liu

Qiaolifanayi Nuermaimaiti

Li Cai

Xiayire Aierken

Xiufang Li

Qin Luo

Jing Hong

Affiliations

Soon will be listed here.

Abstract

Background: Aldosterone is the effector hormone in the renin angiotensin aldosterone system and existing data suggest aldosterone affect cognitive function. However, the relationship between plasma aldosterone concentration (PAC) and cognitive performance remains unexplored in community dwellers. Therefore, we aimed to explore whether PAC is associated with cognitive performance in this population.

Methods: We cross-sectionally enrolled adults using multistage random sampling from Emin, China in 2019. Participants underwent questionnaires and data collection. Cognitive status was assessed using mini-mental state examination (MMSE) questionnaire. Multi-variable linear and logistic regression were used to explore the association between log PAC and log MMSE score, and between tertiled PAC (the higher PAC as the exposure) and low cognitive performance, respectively, in total, apparently healthy and diseased participants. Subgroup analyses also were performed by age, gender, BMI, living region, ethnicity and education attainment status.

Results: 27,707 subjects were included, of whom, 12,862 were apparently healthy and 14,845 had disease. Log-PAC was positively associated with log-MMSE score in the multivariable linear regression in the total ( = 0.01, 95%CI: 0-0.01,  < 0.001), apparently healthy ( = 0.01, 95%CI: 0-0.01,  = 0.007) participants, and the diseased without taking medicine ( = 0.01, 95%CI: 0.01-0.02,  = 0.004) participants. In logistic regression, the highest third tertile of PAC group showed significantly lower odds for the presence of low cognitive performance in total (OR = 0.83, 95%CI: 0.73-0.93,  = 0.002) and diseased without taking medicine participants (OR = 0.70, 95%CI: 0.57-0.86,  < 0.001). Various sub-group analysis showed largely consistent results with the main analysis.

Conclusion: There was a positive correlation between plasma aldosterone and cognitive functions in community dwellers, whereas further studies are need when considering the cross-sectional nature of the current study.

References

Li N, Lee A, Whitmer R, Kivipelto M, Lawler E, Kazis L . Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010; 340:b5465. PMC: 2806632. DOI: 10.1136/bmj.b5465. View

de Kloet E . Hormones and the stressed brain. Ann N Y Acad Sci. 2004; 1018:1-15. DOI: 10.1196/annals.1296.001. View

Qiu S, Champagne D, Peters M, Catania E, Weeber E, Levitt P . Loss of limbic system-associated membrane protein leads to reduced hippocampal mineralocorticoid receptor expression, impaired synaptic plasticity, and spatial memory deficit. Biol Psychiatry. 2010; 68(2):197-204. PMC: 2900390. DOI: 10.1016/j.biopsych.2010.02.013. View

Wu L, He Y, Jiang B, Liu M, Wang J, Yang S . The association between the prevalence, treatment and control of hypertension and the risk of mild cognitive impairment in an elderly urban population in China. Hypertens Res. 2016; 39(5):367-75. PMC: 4865472. DOI: 10.1038/hr.2015.146. View

Royea J, Hamel E . Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets. Geroscience. 2020; 42(5):1237-1256. PMC: 7525853. DOI: 10.1007/s11357-020-00231-y. View

Hinkelmann K, Wingenfeld K, Kuehl L, Fleischer J, Heuser I, Wiedemann K . Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol Aging. 2014; 36(2):919-24. DOI: 10.1016/j.neurobiolaging.2014.09.008. View

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

Nishi S, Babio N, Paz-Graniel I, Serra-Majem L, Vioque J, Fito M . Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study. BMC Med. 2023; 21(1):82. PMC: 9993798. DOI: 10.1186/s12916-023-02771-4. View

Wichmann M, Cruickshanks K, Carlsson C, Chappell R, Fischer M, Klein B . Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc. 2014; 62(9):1683-91. PMC: 4196672. DOI: 10.1111/jgs.12994. View

10.

Morishita R . Aegis against stroke and dementia by angiotensin type 1 receptor blockers: new beneficial aspects. Hypertens Res. 2008; 31(1):1-3. DOI: 10.1291/hypres.31.1. View

11.

Hajjar I, Hart M, Mack W, Lipsitz L . Aldosterone, cognitive function, and cerebral hemodynamics in hypertension and antihypertensive therapy. Am J Hypertens. 2014; 28(3):319-25. PMC: 4402350. DOI: 10.1093/ajh/hpu161. View

12.

Munier M, Law F, Meduri G, Le Menuet D, Lombes M . Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology. 2012; 153(3):1330-40. PMC: 3639543. DOI: 10.1210/en.2011-1436. View

13.

Verpillat P, Alperovitch A, Cambien F, Besancon V, Desal H, Tzourio C . Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology. 2001; 56(5):673-5. DOI: 10.1212/wnl.56.5.673. View

14.

. [2016 Chinese guideline for the management of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016; 44(10):833-853. DOI: 10.3760/cma.j.issn.0253-3758.2016.10.005. View

15.

Trune D, Canlon B . Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken). 2012; 295(11):1928-43. PMC: 3999710. DOI: 10.1002/ar.22576. View

16.

Frisina R, Ding B, Zhu X, Walton J . Age-related hearing loss: prevention of threshold declines, cell loss and apoptosis in spiral ganglion neurons. Aging (Albany NY). 2016; 8(9):2081-2099. PMC: 5076453. DOI: 10.18632/aging.101045. View

17.

Khachaturian A, Zandi P, Lyketsos C, Hayden K, Skoog I, Norton M . Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006; 63(5):686-92. DOI: 10.1001/archneur.63.5.noc60013. View

18.

Artham S, Fouda A, El-Remessy A, Fagan S . Vascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure. Receptors Clin Investig. 2015; 2(3). PMC: 4548973. DOI: 10.14800/rci.774. View

19.

Ahmed A, Cowley D, Wolley M, Gordon R, Xu S, Taylor P . Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study. J Clin Endocrinol Metab. 2014; 99(8):2745-53. DOI: 10.1210/jc.2014-1153. View

20.

Barnes D, Yaffe K . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10(9):819-28. PMC: 3647614. DOI: 10.1016/S1474-4422(11)70072-2. View